Compared with CCNU or TRAF7 inhibition alone, our results found that the count of senescent cells (measured via ß-galactosidase-senescence assay) was markedly increased to glioma sh-TRAF7 cells treated with CCNU (Fig. 5D). The gene discussed is TRAF7; the disease is central nervous system cancer.